SGX Pharmaceuticals, Inc. (SGXP) Submits FDA Investigational New Drug Application
Read the full article: http://blog.qualitystocks.net/?p=11110
SGX Pharmaceuticals is a biopharmaceutical company which focuses mainly on the development and commercialization of new oncological, or cancer therapies. Yesterday, the company announced its submission of an Investigational New Drug (IND) application for FDA approval.
- Login or register to post comments
- Email this page
Related Articles
- Dyax Corp. (DYAX) Reports Statistically Significant Results in Trials to Fight Hereditary Angioedema
- Molecular Insight Pharmaceuticals, Inc. (MIPI) CEO Presents at Healthcare Conference
- Pfocus on Pfizer
- Zynex Inc. (ZYXI.OB) Posts Significant Increases across the Board for Q2
- China Medicine Corporation (CHME.OB) Reports Surge in Second Quarter Profit
